These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 337559)

  • 1. [Treatment of liver diseases, especially of fatty liver with betaine citrate].
    Semmler F
    Ther Ggw; 1977 Nov; 116(11):2113-24. PubMed ID: 337559
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with betain citrate (author's transl)].
    Babucke G; Sarre B
    Med Klin; 1973 Aug; 68(34):1109-13. PubMed ID: 4364431
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new biochemical aspect of liver therapy].
    Gäbler H
    Ther Ggw; 1971 Apr; 110(4):505-14. PubMed ID: 5574294
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of "Essenciale" in the treatment of liver diseases].
    Pogromov AP; Ol'binskaia LI; Antonenko NI; Gitel' NP; Smolianitskiĭ AIa
    Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical results using betaine citrate (Flacar) in fatty livers].
    Hilt G; Tuzin P
    Med Monatsschr; 1973 Jul; 27(7):322-5. PubMed ID: 4731683
    [No Abstract]   [Full Text] [Related]  

  • 6. [Betaine aspartate in the hepato-digestive domain].
    Cachin M; Pergola F
    Sem Ther; 1966 Oct; 42(8):423-4. PubMed ID: 5994378
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic activity of betaine aspartate].
    Nicrosini F
    Clin Ter; 1972 May; 61(3):227-36. PubMed ID: 5050945
    [No Abstract]   [Full Text] [Related]  

  • 8. Betaine and nonalcoholic steatohepatitis.
    Houghton WC
    Am J Gastroenterol; 2003 Dec; 98(12):2803. PubMed ID: 14687837
    [No Abstract]   [Full Text] [Related]  

  • 9. Betaine. Monograph.
    Altern Med Rev; 2003 May; 8(2):193-6. PubMed ID: 12777166
    [No Abstract]   [Full Text] [Related]  

  • 10. [New therapeutic aspects in substitutive treatment with homologous and heterologous enzymes of gastro-entero-biliary hyposthenic diseases].
    Palmari V; Pietranera P
    Clin Ter; 1970 May; 53(4):299-313. PubMed ID: 4918645
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences in liver diseases (specially in patients with fatty liver due to alcoholism and food poisoning) under monotherapy with ornithine aspartate].
    Hunold W
    Z Allgemeinmed; 1973 Apr; 49(10):469-72. PubMed ID: 4580434
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stea 16].
    Med Chir Dig; 1972; 1(3):Suppl:35-40. PubMed ID: 5080085
    [No Abstract]   [Full Text] [Related]  

  • 13. Betaine: an old therapy for a new scourge.
    Neuschwander-Tetri BA
    Am J Gastroenterol; 2001 Sep; 96(9):2534-6. PubMed ID: 11569673
    [No Abstract]   [Full Text] [Related]  

  • 14. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine.
    Patrick L
    Altern Med Rev; 2002 Aug; 7(4):276-91. PubMed ID: 12197781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Betaine aspartate in the therapy of liver diseases].
    Cairella M; Volpari B
    Clin Ter; 1972 Mar; 60(6):513-34. PubMed ID: 5038777
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 18. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
    Abdelmalek MF; Angulo P; Jorgensen RA; Sylvestre PB; Lindor KD
    Am J Gastroenterol; 2001 Sep; 96(9):2711-7. PubMed ID: 11569700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of combined arginine-betaine-sorbitol therapy in the treatment of metabolic liver diseases].
    Abbou R; Mahoudeau D; Dubrisay J; Volteau M
    Sem Hop; 1965 Apr; 41(19):1170-6. PubMed ID: 4284191
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of vitamin E for treatment of experimental liver dystrophy].
    Nesterovich IaM
    Vrach Delo; 1976 Jun; (6):85-7. PubMed ID: 969467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.